The Lancet HIV launched in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title delivers a holistic view of the pandemic, publishing original research, comment, and correspondence that unifies clinical, epidemiological, and operational disciplines across a single vision of health for those living with HIV.
…
continue reading
The Lancet (www.thelancet.com) is a weekly medical journal, renowned for the publication of high-quality peer-reviewed research and reviews from around the world. In the Podcasts our editors discuss journal highlights, including interviews with authors of key articles to provide context and insight to advancements in medicine and health worldwide.
…
continue reading
The Lancet Voice is a fortnightly podcast from the Lancet family of journals. Lancet editors and their guests unravel the stories behind the best global health, policy and clinical research of the day―and what it means for people around the world.
…
continue reading
The Lancet Gastroenterology & Hepatology is a monthly journal that considers original research, reviews, and personal views in gastroenterology and hepatology from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
…
continue reading
The Lancet Psychiatry exists to promote excellence in psychiatric research and practice, and to advocate for the rights of people with mental health problems. Our podcast brings experts together from a wide range of backgrounds to discuss hot topics relevant to mental health in science, society, the law, and the arts. It is vital listening for anyone with an interest in the field.
…
continue reading
The Lancet Respiratory Medicine publishes a range of article types in respiratory medicine and critical care. These include Original Research, Reviews, Personal Views, Comments, and News articles. Topics include but are not limited to asthma, COPD, tobacco control, critical care, lung cancer, cystic fibrosis, pneumonia, sarcoidosis, mesothelioma, sleep medicine, and respiratory infections.
…
continue reading
The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
…
continue reading
With a strong clinical focus, The Lancet Child & Adolescent Health will be an independent journal with an international perspective. The monthly journal will present the most influential and innovative practice-changing original research, as well as authoritative reviews and insightful opinion pieces to promote the health of the whole child, from the fetal period through to young adulthood.
…
continue reading
Sophia Davis, Senior Editor at The Lancet Psychiatry, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from premature mortality in people with mental illness to cranial electrostimulation therapy for depression, the importance of first-person stories to psychological therapy for sleep problems in young people at ris ...
…
continue reading
Jessamy Bagenal, Chloe Wilson, and Callum Davidson—editors at The Lancet—and Gavin Cleaver, The Lancet Group’s Audio Producer, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more.
…
continue reading
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
…
continue reading
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgica ...
…
continue reading
Editors at The Lancet Child & Adolescent Health, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from the effects of climate change to gender equity in young people’s sexual and reproductive health rights, violence against children to allergies, and more.
…
continue reading
Editors at The Lancet Healthy Longevity, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from dementia prevention to older people in the criminal justice system, the haematological malignancies in older people to the link between physical activity, sleep duration, and cognitive ageing, and more.
…
continue reading
Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.
…
continue reading
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
…
continue reading
The Lancet Neurology is a monthly journal, renowned for the publication of high-quality peer-reviewed research, reviews, and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue, with occasional interviews with an author of a key article.
…
continue reading
Editors at The Lancet Rheumatology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from disorders of the immune system to sex and gender in research design, the transitional care for adolescent patients with rheumatic diseases to care for undocumented immigrants, and more.
…
continue reading
The Lancet Haematology launched in Autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice.
…
continue reading
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.
…
continue reading
The Lancet Global Health is the first online-only, open access journal in The Lancet
…
continue reading
If you just so happen to find this and listen to it you’re probably writing a manifesto. Cover art photo provided by wu yi on Unsplash: https://unsplash.com/@takeshi2
…
continue reading
Lan-Lan Smith, Editor-in-Chief, and Emma Cookson, Senior Editor at The Lancet Haematology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from racial and ethnic disparities in leukaemia survival outcomes to resuscitation with blood products compared with saline, the link between mental health and lymphoma to haemol ...
…
continue reading
Editors at The Lancet Global Health, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from the global burden of cervical cancer associated with HIV to financing primary health care, the role of poverty in the misuse of antibiotics to intimate partner violence, and more.
…
continue reading
Editors at The Lancet Microbe, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from using probiotics to reduce Staphylococcus aureus, to phage therapy and monitoring antimicrobial resistance using faecal metagenomes, and more.
…
continue reading
The Lancet Regional Health journals’ editors, in conversation with their authors, explore their latest open access research and its impact on people’s health, healthcare, and health policy. This podcast covers a broad range of topics through a regional lens, from climate change and health adaptation to surgical care capacity in the Pacific Island countries, the determinants of onset and prognosis of long COVID-19 to the opioid crisis in Mexico, and more.
…
continue reading
The Lancet Infectious Diseases is a monthly journal, renowned for the publication of high-quality peer-reviewed reviews and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
…
continue reading
Editors at The Lancet Public Health, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from cervical cancer screening to mental health disorders among migrants, the association between daily steps and mortality risk to the link between air pollution and mortality, and more.
…
continue reading
The Lancet Diabetes and Endocrinology is a monthly journal that publishes high-quality peer-reviewed research, reviews, and analysis from around the world. In the podcasts, editors of the journal discuss timely news, views, research, and reviews in diabetes, endocrinology, and metabolism.
…
continue reading
Editors at The Lancet Diabetes & Endocrinology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from thyroid cancer to childhood obesity, the mechanisms of ageing to erectile dysfunction, and more.
…
continue reading
The Lancet News is a weekly podcast brought to you by The Lancet. Our editors, Tim Dehnel and Dara Mohammadi, report on important, interesting, and sometimes quirky health-related happenings from around the world, while providing a rundown of the latest news from The Lancet, The Lancet Infectious Diseases, The Lancet Neurology, and The Lancet Oncology.
…
continue reading
Our Editors and and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
…
continue reading
Rupa Sarkar, Editor-in-Chief, Diana Samuel, Deputy Editor, Lucy Dunbar, Senior Editor, and Gustavo Monnerat, Senior Editor at The Lancet Digital Health, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from using machine learning to predict mortality in prostate cancer and the need for feminist intersect ...
…
continue reading
Saleha Hassan, Senior Editor at The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from polio eradication in Africa to COVID-19 vaccines in Hong Kong, the treatment of early syphilis in adults to Mpox in the UK, and more.
…
continue reading
1
In conversation with... Akash Deep
21:44
21:44
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
21:44
Professor Akash Deep joins Josefine Gibson in conversation about paediatric acute liver failure and when a critically ill child is unsuitable for liver transplantation.Par The Lancet
…
continue reading
1
Akash Deep on paediatric acute liver failure
21:44
21:44
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
21:44
Professor Akash Deep joins Josefine Gibson in conversation about paediatric acute liver failure and when a critically ill child is unsuitable for liver transplantation. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://l…
…
continue reading
1
In conversation with... Florence Riako Anam and Bruce Richman
25:11
25:11
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
25:11
Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to end AIDS as a public health threat.Par The Lancet
…
continue reading
1
Florence Riako Anam and Bruce Richman on U=U
25:11
25:11
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
25:11
Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to end AIDS as a public health threat. Read the full Article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00241-…
…
continue reading
1
In conversation with... Mikkel Højlund
21:15
21:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
21:15
Sophia Davis talks to Mikkel Højlund about research into the prevalence and outcomes of antipsychotics polypharmacy.Par The Lancet
…
continue reading
1
Mikkel Højlund on antipsychotics polypharmacy
21:15
21:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
21:15
Sophia Davis talks to Mikkel Højlund about research into the prevalence and outcomes of antipsychotics polypharmacy. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/t…
…
continue reading
1
Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis
14:42
14:42
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
14:42
Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00200-0?dgcid=buzzsprout_icw_podcast_generic_langas Continue this co…
…
continue reading
1
In conversation with... Peter De Cruz
14:42
14:42
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
14:42
Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis.Par The Lancet
…
continue reading
1
Nusrat Husain, Farah Lunat, and Fehmida Motala on postnatal depression in British south Asian women (the ROSHNI-2 trial)
48:44
48:44
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
48:44
ROSHNI-2 was a multicentre, randomised controlled trial that investigated the efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women. Joining us to share their expertise and perspectives are chief investigator Professor Nusrat Husain, trial manager Farah Lunat, and se…
…
continue reading
1
In conversation with... Nusrat Husain, Farah Lunat, and Fehmida Motala
48:44
48:44
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
48:44
ROSHNI-2 was a multicentre, randomised controlled trial that investigated the efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women. Joining us to share their expertise and perspectives are chief investigator Professor Nusrat Husain, trial manager Farah Lunat, and se…
…
continue reading
1
Dr Iracema Leroi on a hearing and vision rehabilitation intervention for people with dementia
18:51
18:51
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:51
Dr Iracema Leroi discusses the SENSE-Cog trial on the effects of a hearing and vision rehabilitation and support programme on quality of life in people living with dementia. Read the full article: https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00141-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhl Continue this conversation …
…
continue reading
1
Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma
15:07
15:07
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
15:07
Dr Steven Horwitz (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a phase 1 study of valemetostat in relapsed or refractory non-Hodgkin lymphoma and a phase 2 study of valemetostat in relapsed or refractory peripheral T-cell lymphoma. Read the full Articles here: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(…
…
continue reading
1
In conversation with... Steven Horwitz
15:07
15:07
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
15:07
Dr Steven Horwitz (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a phase 1 study of valemetostat in relapsed or refractory non-Hodgkin lymphoma and a phase 2 study of valemetostat in relapsed or refractory peripheral T-cell lymphoma.Par The Lancet
…
continue reading
1
Reducing premature deaths, the limits of human longevity, and healthy cities
42:55
42:55
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
42:55
Gavin, Richard, and Jessamy get into the studio for another bonus episode looking at the launch of the Global Health 2050 report at the World Health Summit in Berlin, a report which shows a path to cutting premature mortality by 50% by 2050. Also up for discussion are the limits of human longevity and what well-designed cities mean for health. Send…
…
continue reading
1
Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)
10:26
10:26
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:26
Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM). Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal ht…
…
continue reading
1
In conversation with... Sergio Harari
10:26
10:26
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:26
Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).Par The Lancet
…
continue reading
1
Sebastian Sattui on older adults with ANCA-associated vasculitis
25:54
25:54
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
25:54
Dr Sebastian Sattui discusses the effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Read the full article: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00193-0/fulltext?dgcid=buzzsprout_icw_podca…
…
continue reading